CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more news2026-09-05T10:00:45+00:00September 5th, 2026|Endpoints News|
Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and morenews2026-08-29T10:00:51+00:00August 29th, 2026|Endpoints News|
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and morenews2026-08-22T10:00:07+00:00August 22nd, 2026|Endpoints News|
Trump’s MMR order; LSD drug clears Phase 3 test; and morenews2026-08-15T10:00:56+00:00August 15th, 2026|Endpoints News|
Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and morenews2026-08-08T10:00:08+00:00August 8th, 2026|Endpoints News|
Alnylam’s slump deepens; Q2 earnings roundup; and morenews2026-08-01T10:00:38+00:00August 1st, 2026|Endpoints News|
Anthropic’s life science plans; Novartis CEO on China deals; and more news2026-07-25T10:00:11+00:00July 25th, 2026|Endpoints News|
Biogen’s mixed Alzheimer’s data; Two new startups launch; and morenews2026-07-18T10:00:14+00:00July 18th, 2026|Endpoints News|
Biogen’s mixed Alzheimer’s data; Two new startups launch; and morenews2026-07-18T10:00:14+00:00July 18th, 2026|Endpoints News|
Deals, deals, deals; Biohaven takes on Eli Lilly; and morenews2026-07-11T10:00:33+00:00July 11th, 2026|Endpoints News|
